| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/02/2004 | USRE38452 Heterocyclic amines having central nervous system activity |
| 03/02/2004 | US6699989 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/02/2004 | US6699883 Antibiotics, bactericides, antitumor |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 03/02/2004 | US6699876 Camptothecin analogue compounds |
| 03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
| 03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
| 03/02/2004 | US6699864 Substituted phenyl-piperazine derivatives, their preparation and use |
| 03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
| 03/02/2004 | US6699852 Substituted pyridoindoles as serotonin agonists and antagonists |
| 03/02/2004 | US6699717 Changes in its luminescence lifetime characteristic/intensity as a function of the polarity; a sensor, probe; uses imine ligands to detect presence, amount or concentration of a polar solvent |
| 03/02/2004 | CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/26/2004 | WO2004016741A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use |
| 02/26/2004 | WO2004016617A1 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists |
| 02/26/2004 | WO2004016616A1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. |
| 02/26/2004 | WO2004016611A1 Use of and some novel imidazopyridines |
| 02/26/2004 | WO2004016610A1 Substituted pyrrolopyridines |
| 02/26/2004 | WO2004016609A1 Substituted pyrrolopyridines |
| 02/26/2004 | WO2004016607A1 Inhibition of phosphoinositide 3-kinase beta |
| 02/26/2004 | WO2004016604A2 Azabicyclic compounds are central nervous system active agents |
| 02/26/2004 | WO2004016592A1 Prenylation inhibitors and methods of their synthesis and use |
| 02/26/2004 | WO2004016086A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 02/26/2004 | WO2004003599A3 Anisotropic films based on 1,8-naphthoylene-1',2'-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
| 02/26/2004 | WO2003103584A3 Ether substituted imidazopyridines |
| 02/26/2004 | WO2003103575A3 Compounds, compositions, and methods |
| 02/26/2004 | WO2003090677A3 Somatostatin analogue compounds |
| 02/26/2004 | WO2003076398A3 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors |
| 02/26/2004 | WO2003039549A8 Selective antibacterial agents |
| 02/26/2004 | WO2003027110A3 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones |
| 02/26/2004 | WO2002083683A9 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 02/26/2004 | US20040039040 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 02/26/2004 | US20040039029 Thiazolyl urea compounds and methods of uses |
| 02/26/2004 | US20040039013 Process for preparing a substituted imidazopyridine compound |
| 02/26/2004 | US20040039012 Nitrogen compounds such as Benzyl-8-methyl-5,7-dioxo-1,5,6,7-tetrahydro-(1,2,4)triazolo(1,5-a)pyridine -2-carboxylic acid benzylamide, used for prophylaxis of arthritis, inflammation or cancer |
| 02/26/2004 | US20040039009 Nitrogen compounds such as 5,6-dihydro-5,11-diketo-11H-indeno (1,2-c)isoquinoline, used as poly/ADP-ribose/ synthase inhibitors in cells, and for prophylaxis of reperfusion injuries, diabetes or inflammation |
| 02/26/2004 | US20040039007 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 02/26/2004 | US20040039000 6-aminofuro(2,3-d)pyrimidines and 6-aminopyrrolo(2,3-d) pyrimidines useful in treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii |
| 02/26/2004 | US20040038999 6-alkoxy-pyrido-pyrimidines |
| 02/26/2004 | US20040038998 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity |
| 02/26/2004 | US20040038980 Imidazo-heterobicycles as factor xa inhibitors |
| 02/26/2004 | US20040038978 Chemical compounds |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038975 Effective against a broad range of pathogenic microorganisms with advantages in low susceptibility to microbial resistance, reduced toxicity, and improved pharmacology. |
| 02/26/2004 | US20040038973 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038970 Substituted with an imidazole ring; binds to somatostatin receptors and blocks Na channels; especially for treating arrhythmia and epilepsy |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038963 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 02/26/2004 | US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/26/2004 | US20040038961 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/26/2004 | US20040038960 Treating arthritis |
| 02/26/2004 | US20040038959 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038957 Anti-malarial activity |
| 02/26/2004 | CA2495589A1 Azabicyclic compounds are central nervous system active agents |
| 02/26/2004 | CA2495511A1 Use of and some novel imidazopyridines |
| 02/26/2004 | CA2493920A1 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists |
| 02/26/2004 | CA2493246A1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists |
| 02/25/2004 | EP1391461A1 Bicyclic lactam inhibitors of interleukin-1-beta converting enzyme |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391454A1 Substituted benzamide compounds with antihypertensive activity |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1390367A1 DIHYDROIMIDAZO 5,1-A]-$G(b)-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE |
| 02/25/2004 | EP1390366A1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 02/25/2004 | EP1390365A1 Novel sulfonate substituted pyrazol pyridine dervivatives |
| 02/25/2004 | EP1390362A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 02/25/2004 | EP1390350A1 Novel compounds |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
| 02/25/2004 | EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 02/25/2004 | EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 02/25/2004 | EP1206469B1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 02/25/2004 | EP1140931B1 5ht1 antagonists for antidepressant therapy |
| 02/25/2004 | EP1080090B1 Antitumour 1,5-diazaanthraquinones |
| 02/25/2004 | EP0984967B1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 02/25/2004 | EP0758897B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 02/25/2004 | CN1478090A Substituted imidazopyridines |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1139589C Tetrahydroimidazo [2,1-a] isoquinoline derivatives |
| 02/24/2004 | US6696566 Selective p38 kinase inhibitors relative to cyclin-dependent kinases and tyrosine kinases |
| 02/24/2004 | US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes |
| 02/24/2004 | US6696465 Sulfonamido substituted imidazopyridines |
| 02/24/2004 | US6696464 Triazolo-pyridines anti-inflammatory compounds |
| 02/24/2004 | US6696461 Tricyclic imidazopyridines |
| 02/24/2004 | US6696460 Prevention and treatment of gastrointestinal diseases |
| 02/24/2004 | US6696459 Using high affinity, high selectivity quinoline derivativesw |
| 02/24/2004 | US6696457 Morphinoid compounds |
| 02/24/2004 | US6696456 Carbocyclic acids and salts such as (2s,3r)-3-ethylsulfanyl-2-(4'-fluoro-biphenyl-4-sulfonylamino)-3- phenylpropionic acid, used as metalloenzyme antagonists for the prophylaxis of degenerative joint disease and as wound healing agents |
| 02/24/2004 | US6696455 Nitrogen compounds such as 6-chloro-2-methyl-4-oxo-pyrido (3,2-d)pyrimidine used as anticarcinogenic agents and/or for prophylaxis of infections caused by pneumocystis or toxoplasma |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents |
| 02/24/2004 | US6696434 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 02/24/2004 | US6696076 Administering imidazoquinoline amine or imidazopyridine amine as interleukin and cytokine inhibitor |
| 02/24/2004 | US6696039 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 02/19/2004 | WO2004014921A1 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014917A2 Antitumoral analogs of lamellarins |